The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells

Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the stud...

Повний опис

Збережено в:
Бібліографічні деталі
Опубліковано в: :Experimental Oncology
Дата:2012
Автори: Todor, I.N., Lukianova, N.Yu., Chekhun, V.F.
Формат: Стаття
Мова:Англійська
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/138697
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862718991264382976
author Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
author_facet Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
citation_txt The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the study. Cholesterol, total lipids and phospholipids content were determined by means of thin-layer chromatography. Results. It was found that cholesterol as well as cholesterol ethers content are significantly higher but diacylglycerols, triacyl­glycerols content are significantly lower in resistant cell strains than in parental (sensitive) cells. Moreover the analysis of individual phospholipids showed the increase of sphingomyelin, phosphatidylserine, cardiolipin, phosphatidic acid and the decrease of phosphatidy­lethanolamine, phosphatidylcholine in MCF-7/CP and MCF-7/Dox cells. Conclusion. Obtained results allow to suggest that the lipid profile changes can mediate the modulation of membrane fluidity in drug resistant MCF-7 breast cancer cells.
first_indexed 2025-12-07T18:18:30Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-138697
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T18:18:30Z
publishDate 2012
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
2018-06-19T11:49:01Z
2018-06-19T11:49:01Z
2012
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/138697
Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the study. Cholesterol, total lipids and phospholipids content were determined by means of thin-layer chromatography. Results. It was found that cholesterol as well as cholesterol ethers content are significantly higher but diacylglycerols, triacyl­glycerols content are significantly lower in resistant cell strains than in parental (sensitive) cells. Moreover the analysis of individual phospholipids showed the increase of sphingomyelin, phosphatidylserine, cardiolipin, phosphatidic acid and the decrease of phosphatidy­lethanolamine, phosphatidylcholine in MCF-7/CP and MCF-7/Dox cells. Conclusion. Obtained results allow to suggest that the lipid profile changes can mediate the modulation of membrane fluidity in drug resistant MCF-7 breast cancer cells.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
Article
published earlier
spellingShingle The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
Todor, I.N.
Lukianova, N.Yu.
Chekhun, V.F.
Original contributions
title The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_full The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_fullStr The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_full_unstemmed The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_short The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
title_sort lipid content of cisplatin- and doxorubicin-resistant mcf-7 human breast cancer cells
topic Original contributions
topic_facet Original contributions
url https://nasplib.isofts.kiev.ua/handle/123456789/138697
work_keys_str_mv AT todorin thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT lukianovanyu thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT chekhunvf thelipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT todorin lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT lukianovanyu lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells
AT chekhunvf lipidcontentofcisplatinanddoxorubicinresistantmcf7humanbreastcancercells